ReAct Interview
Your life can change in a split second. Vanessa Carter from South Africa is well aware of this. She was in a car accident 17 years ago.
On top of the accident she also survived 3 years of a drug-resistant infection. Despite this, she stayed strong and felt a need to create change. She became a patient advocate for antibiotic resistance and is now widely engaged, completed a Stanford Medicine X e-Patient Scholarship and holds a position in the WHO Strategic Advisory Group (STAG) for AMR. She says: “It is not just me, there are other patients as well.”
Policy
At the time of the UN High-level Interactive Dialogue on Antimicrobial Resistance taking place today, it is a cold reality that identified barriers and systems challenges common to COVID-19 and antibiotic resistance remain valid today, while coordinated action has not kept pace on a global scale. It should be a wake-up call and time is ticking for the global community to walk the talk on antibiotic resistance, of which the individual and societal consequences are more detrimental and far reaching.
ReAct Interview
Beginning March, the The Strategic and Technical Advisory Group for Antimicrobial resistance (STAG-AMR) had its first meeting. The group is the principal advisory group to the World Health Organization (WHO) on antimicrobial resistance. Both Otridah Kapona, AMR Focal Point for Zambia and Projects Officer at ReAct Africa and Sujith Chandy, Director of ReAct Asia Pacific, was appointed to the group. We have asked the two new STAG-AMR members a few questions about the newly formed advisory group and their hopes for the future. Of course, ReAct also congratulates to their new appointment!
ReAct Report
While the world is caught up in responding to the COVID-19 pandemic, it has gone largely unnoticed that more than thirty years has passed since the last class of antibiotics was discovered. Meanwhile global consumption of antibiotics continues to increase. In response, bacteria have developed resistance and are spreading as a silent but steady pandemic threatening to devastate healthcare and modern medicine as we know it.
Expert Conversation
ReAct Europe organized an ‘Expert Conversation’ event to mark the launch of their new report “Ensuring sustainable access to effective antibiotics for everyone, everywhere – How to address the crisis in antibiotic research and development” on the 14th of April. Read more and look at conversation.
Policy
Due to COVID-19, pandemic preparedness and global health security have emerged as the dominating approach to addressing public health crises, of which antimicrobial resistance has been among the priority list. This piece highlights considerations for antimicrobial resistance to be addressed through the pandemic preparedness lens.
ReAct Interview
Dr Meenakshi Gautham is a Research Fellow in Health Systems and Policy at the London School of Hygiene and Tropical Medicine. She is currently leading a study to design a One Health Antibiotic Stewardship Intervention in community settings in rural India. In the project she is working with informal health providers and para-vets, the formal public health and veterinary health systems, the pharmaceutical industry and rural communities. Her whole interest in antibiotic use started because of her interest in informal providers.
Policy
Antimicrobial resistance was back on the agenda when the 148th WHO Executive Board which took place from January 18-26. A number of ReAct’s nodes developed position documents for Member State delegates and the WHO to consider in response to the stock taking report produced by the WHO secretariat.
Viewpoint in media
Viewpoint published in Brookings Foresight Africa 2021 report written by Patricia Geli, Senior Economist and Public Health Specialist at the World Bank and Professor Otto Cars, founder of ReAct.
While wealthier countries have been able to kick the can down the road by switching to more expensive antibiotics, already-fragile health systems in Africa will be stretched beyond breaking point as the switch from first-line antibiotics adds a median overall cost of $700 per infection.
News
React Africa and South Centre hosted their third annual conference beginning December 2020, under the theme, “What is the status of the Antimicrobial Resistance National Action Plans in the African Region?”A full conference report will be shared within 3 weeks. At a glance though, there where 4 key takeaways from the conference. To access the report e-mail: musonda.lamba@reactafrica.org
Science
The World Health Organization (WHO) classify antimicrobial resistance as one of the ten most considerable global public health threats humanity is facing. Medical and scientific communities have been aware for a long time. Still, the global burden of antibiotic resistance remains unknown.
ReAct Interview
Nurse Dorce Datu, head of the Neonatal Intensive Care Unit at Biak Hospital, Indonesia, has been working in the unit since the first day it was founded. She has seen the days when the death rate of premature babies with infection was 100%, and now she is the one who keeps the Infection Prevention Control Program at the unit running.
Her main goal is to create a supportive environment for the staff and she is not afraid of going the extra mile to help them and their small patients. She is a nurse who – together with the unit and the hospital – acts conscientiously on antibiotic resistance. We need more nursing professionals like Nurse Dorce and her team.